Fortress Biotech, Inc. (FBIO) Nonoperating Income (Expense) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Fortress Biotech, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2024.
  • Fortress Biotech, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$2.46 M, a 166% decline year-over-year.
  • Fortress Biotech, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$17.5 M, a 340% decline year-over-year.
  • Fortress Biotech, Inc. annual Nonoperating Income (Expense) for 2023 was -$11.3 M, a 14.1% decline from 2022.
  • Fortress Biotech, Inc. annual Nonoperating Income (Expense) for 2022 was -$9.9 M, a 141% decline from 2021.
  • Fortress Biotech, Inc. annual Nonoperating Income (Expense) for 2021 was $24.2 M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$17.5 M -$2.46 M -$6.18 M -166% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$11.3 M -$8.99 M -$6.63 M -281% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$4.66 M $3.18 M +$5.5 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$10.2 M -$9.2 M -$6.19 M -206% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$3.97 M $3.72 M +$5.93 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$9.9 M -$2.36 M -$71 K -3.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$9.83 M -$2.33 M -$6.39 M -157% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$3.44 M -$3 M -$21.5 M -116% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $18 M -$2.21 M -$6.16 M -156% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $24.2 M -$2.29 M -$6.24 M -158% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $30.4 M $4.06 M +$11 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $19.4 M $18.5 M +$21.5 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$2.09 M $3.95 M +$6.49 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$8.58 M $3.95 M +$6.52 M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$15.1 M -$6.92 M -$4.49 M -185% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$10.6 M -$3.07 M -$877 K -40% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$9.73 M -$2.54 M -$18.9 M -116% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $9.16 M -$2.57 M -$163 K -6.76% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 $9.32 M -$2.43 M +$595 K +19.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $8.73 M -$2.19 M +$1.21 M +35.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $7.52 M $16.4 M +$18.3 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$10.8 M -$2.41 M +$4.86 M +66.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$15.7 M -$3.03 M +$679 K +18.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$16.3 M -$3.4 M -$3.64 M -1492% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$12.7 M -$1.97 M -$4.99 M -165% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$7.72 M -$7.27 M -$5.21 M -252% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$2.51 M -$3.7 M -$2.99 M -422% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $484 K $244 K +$1.5 M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$1.01 M $3.02 M +$4.57 M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$5.58 M -$2.07 M +$384 K +15.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$5.96 M -$710 K +$1.07 M +60.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$7.04 M -$1.25 M -$2.6 M -193% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$4.44 M -$1.55 M -$1.09 M -234% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$3.35 M -$2.45 M -$3.7 M -296% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $345 K -$1.78 M -$1.54 M -625% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.88 M $1.34 M +$1.29 M +2485% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $590 K -$464 K +$324 K +41.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $266 K $1.25 M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$246 K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $52 K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$788 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.